Successful treatment of refractory palmoplantar pustulosis by upadacitinib: report of 28 patients

Na Du, Jingyi Yang, Yiwen Zhang, Xinyan Lv, Lei Cao, Wei Min

DOI: 10.3389/fmed.2024.1476793

---

• What is this paper about?

  This paper studies the use of upadacitinib to treat palmoplantar pustulosis (PPP), not atopic dermatitis. Since this paper does not focus on atopic dermatitis treatment, I cannot provide a relevant summary for atopic dermatitis patients.

• How did the authors study this?

  [blank - not relevant for atopic dermatitis]

• What populations did the authors study?

  [blank - not relevant for atopic dermatitis]

• What did the authors find?

  [blank - not relevant for atopic dermatitis]

• What conclusions can we draw?

  [blank - not relevant for atopic dermatitis] The paper mentions atopic dermatitis only briefly as one of the approved indications for upadacitinib but does not provide any meaningful information about its use in atopic dermatitis treatment.